222 related articles for article (PubMed ID: 9421299)
1. Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram.
Buttini M; Mir A; Appel K; Wiederhold KH; Limonta S; Gebicke-Haerter PJ; Boddeke HW
Br J Pharmacol; 1997 Dec; 122(7):1483-9. PubMed ID: 9421299
[TBL] [Abstract][Full Text] [Related]
2. Effects of rolipram, a selective inhibitor of type 4 phosphodiesterase, on lipopolysaccharide-induced uveitis in rats.
Chi ZL; Hayasaka S; Zhang XY; Hayasaka Y; Cui HS
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2497-502. PubMed ID: 15277469
[TBL] [Abstract][Full Text] [Related]
3. Effects of rolipram on cyclic AMP levels in alveolar macrophages and lipopolysaccharide-induced inflammation in mouse lung.
Gonçalves de Moraes VL; Singer M; Vargaftig BB; Chignard M
Br J Pharmacol; 1998 Feb; 123(4):631-6. PubMed ID: 9517381
[TBL] [Abstract][Full Text] [Related]
4. The role of TNF-alpha and its receptors in the production of Src-suppressed C kinase substrate by rat primary type-2 astrocytes.
Yan M; Xia C; Cheng C; Shao X; Niu S; Liu H; Shen A
Brain Res; 2007 Dec; 1184():28-37. PubMed ID: 17980351
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
Seldon PM; Barnes PJ; Giembycz MA
Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
[TBL] [Abstract][Full Text] [Related]
6. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
7. Maternally-administered lipopolysaccharide (LPS) increases tumor necrosis factor alpha in fetal liver and fetal brain: its suppression by low-dose LPS pretreatment.
Ning H; Wang H; Zhao L; Zhang C; Li XY; Chen YH; Xu DX
Toxicol Lett; 2008 Jan; 176(1):13-9. PubMed ID: 18060704
[TBL] [Abstract][Full Text] [Related]
8. A canine model for determination of the therapeutic index of cytokine inhibitors.
Sekut L; Han B; Baer P; Verghese MW; Silverstein R; Clifton L; Dennis S; Numerick MJ; Connolly KM
Lab Anim Sci; 1995 Dec; 45(6):647-51. PubMed ID: 8746524
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.
Barton CC; Barton EX; Ganey PE; Kunkel SL; Roth RA
Hepatology; 2001 Jan; 33(1):66-73. PubMed ID: 11124822
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition.
Turner CR; Esser KM; Wheeldon EB
Circ Shock; 1993 Mar; 39(3):237-45. PubMed ID: 8384094
[TBL] [Abstract][Full Text] [Related]
11. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
[TBL] [Abstract][Full Text] [Related]
12. Effects of dexamethasone, ibuprofen, and ligustrazini on lipopolysaccharides-induced tumor necrosis factor alpha production.
Qiu HB; Pan JQ; Du B; Zhao YQ; Chen DC
Zhongguo Yao Li Xue Bao; 1997 Jan; 18(1):67-70. PubMed ID: 10072898
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
14. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
[TBL] [Abstract][Full Text] [Related]
15. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo.
Li YY; Wong LY; Cheung BM; Hwang IS; Tang F
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1110-8. PubMed ID: 16445578
[TBL] [Abstract][Full Text] [Related]
16. Effects of ketamine/xylazine on expression of tumor necrosis factor-alpha, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia.
Helmer KS; Cui Y; Chang L; Dewan A; Mercer DW
Shock; 2003 Jul; 20(1):63-9. PubMed ID: 12813371
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cAMP-dependent inhibition of LPS-induced TNF alpha production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor.
Prabhakar U; Lipshutz D; Bartus JO; Slivjak MJ; Smith EF; Lee JC; Esser KM
Int J Immunopharmacol; 1994 Oct; 16(10):805-16. PubMed ID: 7843852
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
19. Lps induces IL-6 in the brain and in serum largely through TNF production.
Ghezzi P; Sacco S; Agnello D; Marullo A; Caselli G; Bertini R
Cytokine; 2000 Aug; 12(8):1205-10. PubMed ID: 10930297
[TBL] [Abstract][Full Text] [Related]
20. Synthetic triglyceride containing an arachidonic acid branch (8A8) prevents lipopolysaccharide-induced liver injury.
Piao N; Ikejima K; Kon K; Aoyama T; Osada T; Takei Y; Sato N; Watanabe S
Life Sci; 2009 Oct; 85(17-18):617-24. PubMed ID: 19647752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
